Electroconvulsive Therapy-Induced Mania in Bipolar Disorder: A Case Report.

Cureus

Psychiatry, Psychiatrisch Ziekenhuis Asster, Sint-Truiden, BEL.

Published: December 2024

Electroconvulsive therapy (ECT) is widely recognized as a safe and effective intervention for treating severe affective episodes in patients with bipolar disorder. However, it can sometimes precipitate unexpected manic phases in patients treated for a depressive episode, a phenomenon known as ECT-induced mania. While this occurrence is recognized, it remains poorly understood and minimally addressed in the literature. This article presents a case study of a 56-year-old man diagnosed with bipolar I disorder with rapid cycling and late-onset features who received ECT to treat a severe depressive episode with psychotic and catatonic features but developed a manic episode with psychotic elements shortly after ECT initiation. The onset of mania coincided with the discontinuation of valproate, which may have further increased the likelihood of a mood switch. A literature review suggests four main clinical strategies for managing ECT-induced mania: (1) cessation of ECT, (2) cessation of ECT and initiation of pharmacotherapy, (3) continuation of ECT, and (4) continuation of ECT alongside the addition of lithium as a mood stabilizer. However, the limited and primarily case-based nature of existing research makes it challenging to establish universally applicable treatment guidelines. In the described case, treatment was modified by temporarily suspending ECT and introducing lithium, which helped stabilize the patient's manic symptoms. ECT was later resumed with lithium maintenance, achieving improved mood stability. This case highlights the complexities associated with ECT in bipolar disorder, particularly the potential for manic induction, especially when mood stabilizers are withdrawn. It underscores the need for rigorous patient assessment and monitoring, as well as further research to clarify optimal management strategies and preventive measures for ECT-induced mania.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701791PMC
http://dx.doi.org/10.7759/cureus.75255DOI Listing

Publication Analysis

Top Keywords

bipolar disorder
16
ect-induced mania
12
ect
10
depressive episode
8
episode psychotic
8
ect initiation
8
cessation ect
8
continuation ect
8
mania
5
electroconvulsive therapy-induced
4

Similar Publications

Gene Variant Related Neurological and Molecular Biomarkers Predict Psychosis Progression, with Potential for Monitoring and Prevention.

Int J Mol Sci

December 2024

Department of Psychiatry, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA 5000, Australia.

The ( C677T gene polymorphism is associated with neurological disorders and schizophrenia. Patients diagnosed with schizophrenia and schizoaffective disorder and controls ( 134) had data collected for risk factors, molecular and neuro-sensory variables, symptoms, and functional outcomes. Promising gene variant-related predictive biomarkers were identified for diagnosis by Receiver Operating Characteristics and for illness duration by linear regression.

View Article and Find Full Text PDF

Lumateperone is a novel antipsychotic recently approved for the treatment of schizophrenia. Its unique pharmacological profile includes modulation of serotonergic, dopaminergic, and glutamatergic neurotransmission, differentiating it from other second-generation antipsychotics. This paper explores the pharmacological features and clinical potential of lumateperone across neuropsychiatric conditions.

View Article and Find Full Text PDF

Lithium, Inflammation and Neuroinflammation with Emphasis on Bipolar Disorder-A Narrative Review.

Int J Mol Sci

December 2024

Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Zlotowski Center for Neuroscience and Zelman Center-The School of Brain Sciences and Cognition, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.

This narrative review examines lithium's effects on immune function, inflammation and cell survival, particularly in bipolar disorder (BD) in in vitro studies, animal models and clinical studies. In vitro studies show that high lithium concentrations (5 mM, beyond the therapeutic window) reduce interleukin (IL)-1β production in monocytes and enhance T-lymphocyte resistance, suggesting a protective role against cell death. Lithium modulates oxidative stress in lipopolysaccharide (LPS)-activated macrophages by inhibiting nuclear factor (NF)-ƙB activity and reducing nitric oxide production.

View Article and Find Full Text PDF

The relationship between unemployment and mental disorders has been a significant subject of study since at least the Industrial Revolution. However, most data show associations of unemployment and isolated mental disorders, and this study field has been neglected in the last years. Therefore, this narrative review aims to provide an updated overview of the association between unemployment and mental health in general as well as the most prevalent mental disorders.

View Article and Find Full Text PDF

Neuromodulation Strategies in Lifelong Bipolar Disorder: A Narrative Review.

Behav Sci (Basel)

December 2024

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazza Aldo Moro, 100165 Rome, Italy.

Bipolar disorder is a debilitating psychiatric condition characterized by recurrent episodes of mania and depression, affecting millions worldwide. While pharmacotherapy remains the cornerstone of treatment, a significant proportion of patients exhibit inadequate response or intolerable side effects to conventional medications. In recent years, neuromodulation techniques have emerged as promising adjunctive or alternative treatments for bipolar disorder.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!